CFO
Beta Drugs Limited
Equibles does not estimate personal net worth.
Nippun Narura is recorded as CFO at Beta Drugs Limited. Nippun Narura has spoken on 2 earnings calls across 1 company, most recently for Beta Drugs Limited on October 22, 2026. Beta Drugs Limited is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“So, our cost of debt generally varies between 8% to 9%. And if you were comparing last year's cost of debt, last year there were convertible debentures on which an interest of close to 7-7.5% we used to pay.”
“On behalf of Philip Capital Private Client System Group Desk, I welcome all of you to the Q4 and FI26 earnings conference call of beta drugs and tests.”
Beta Drugs Limited
CFO
Transcript header (unverified)
Beta Drugs Limited
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Earnings Call
Beta Drugs Limited
Earnings Call
Beta Drugs Limited
